| Attribute | Value | [1]
|----------|-------|
| Symbol | RPL7 |
| Name | Ribosomal Protein L7 |
| Chromosome | 8q12.1 |
| NCBI Gene ID | 6130 |
| UniProt ID | P18124 |
| Ensembl ID | ENSG00000101290 |
| Aliases | L7, SAHM1 |
| OMIM | 180436 |
RPL7 (Ribosomal Protein L7) encodes a component of the large 60S ribosomal subunit. While ribosomal proteins were historically viewed as structural components essential for protein synthesis, emerging research has revealed that RPL7 and other ribosomal proteins play crucial roles in various cellular processes beyond translation, including regulation of gene expression, cell cycle control, and neuronal function 1. The involvement of ribosomal proteins in neurodegenerative diseases, particularly Alzheimer's disease (AD) and Parkinson's disease (PD), has become an area of intense investigation 2.
RPL7 is a constituent of the 60S large ribosomal subunit, where it participates in the peptidyl transferase reaction and contributes to the structural integrity of the ribosome 3. The protein contains an N-terminal acidic domain and a C-terminal basic DNA-binding domain, allowing it to interact with both RNA and DNA molecules 4.
Beyond its canonical role in translation, RPL7 has been implicated in several extra-ribosomal functions:
Regulation of Gene Expression: RPL7 can function as a transcription factor, binding to specific DNA sequences and modulating gene expression 5.
Cell Cycle Regulation: Studies have shown that RPL7 interacts with cell cycle regulators and can influence proliferation in certain cell types 6.
Apoptosis Regulation: RPL7 has been reported to interact with p53 and other apoptosis-related proteins, suggesting a role in programmed cell death 7.
Neuroprotective Functions: In neurons, RPL7 may contribute to cellular stress responses and protection against toxic insults 8.
RPL7 is ubiquitously expressed across all tissues, with high expression levels in metabolically active tissues including brain, liver, and kidney. Within the brain, RPL7 is expressed in various regions including the hippocampus, cortex, cerebellum, and substantia nigra 9.
Ribosomal dysfunction is increasingly recognized as a key feature of Alzheimer's disease. Several studies have documented alterations in ribosomal protein expression and function in AD brain tissue:
Translation Impairment: Post-mortem studies of AD brain reveal significant reductions in ribosomal protein levels and translation efficiency, which correlate with cognitive decline 10.
RPL7 Downregulation: Specific downregulation of RPL7 has been observed in the hippocampus of AD patients, potentially contributing to impaired protein synthesis essential for synaptic plasticity and memory 11.
Amyloid-β Impact: Amyloid-β peptides directly inhibit ribosomal function, including the activity of RPL7 and other ribosomal proteins, leading to deficits in local protein synthesis at synapses 12.
Tau Pathology: Hyperphosphorylated tau disrupts ribosomal function by interfering with the interaction between ribosomal proteins and mRNA, exacerbating translation deficits 13.
RPL7 and other ribosomal proteins are implicated in PD through several mechanisms:
Alpha-Synuclein Toxicity: Studies show that alpha-synuclein aggregation can impair ribosomal function, including RPL7-mediated translation 14.
Mitochondrial Dysfunction: Ribosomal proteins, including RPL7, may be involved in the mitochondrial stress response in dopaminergic neurons 15.
LRRK2 Connection: Mutations in LRK2 (leucine-rich repeat kinase 2), a major genetic cause of familial PD, affect ribosomal function and protein synthesis 16.
Neuroinflammation: In PD, inflammatory cytokines can alter ribosomal protein expression, including RPL7, contributing to translational deficits in microglia and neurons 17.
RPL7 dysregulation has been implicated in ALS pathogenesis:
Stress Granule Formation: RPL7 participates in stress granule formation, which is dysregulated in ALS 18.
TDP-43 Pathology: TDP-43 proteinopathy, a hallmark of ALS, affects ribosomal function and may alter RPL7 expression 19.
RPL7 alterations have been documented in:
Understanding RPL7's role in neurodegeneration opens potential therapeutic avenues:
Translation Modulation: Compounds that enhance ribosomal function or restore RPL7 levels may improve protein synthesis in neurodegenerative conditions 23.
Neuroprotective Strategies: Targeting RPL7-associated pathways could protect neurons from various toxic insults.
Biomarker Potential: RPL7 expression levels in cerebrospinal fluid or blood may serve as biomarkers for neurodegeneration 24.
While RPL7 is not a major disease-causing gene in neurodegeneration, several polymorphisms have been studied:
Key areas of ongoing research include: